Altasciences announced the appointment of James Brazeal as General Manager, Clinical Operations, at its clinical facility in Kansas City.

James joins Altasciences having previously worked as Vice President of Research at Akron Children’s Hospital, and most recently as Vice President of Research Operations for Circuit Clinical.

“James’ proven leadership skills, and deep knowledge of all phases of clinical research, will be invaluable in delivering expert guidance for our clients along their early-phase clinical journey,” said Ingrid Holmes, Vice President, Clinical Operations, Altasciences.

With close to a decade of experience in the healthcare and pharmaceutical sectors, including clinical pharmacology, James will apply his knowledge to oversee the day-to-day management of clinical operations at Altasciences’ 140-bed, Phase I, clinical pharmacology unit in Kansas City.

“It is rewarding to be joining a team that has been in place for almost three decades, a team committed to quality, excellence, integrity, and respect—focused on helping to bring better therapies to the patients who need them, faster,” says James.

About Altasciences

Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster. To learn more about Altasciences, visit altasciences.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240129556297/en/

Julie-Ann Cabana
Altasciences
+1 514 601-9763
jcabana@altasciences.com

Logo

Tags

More Like This

Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia, Missouri

Altasciences Receives 2024 CRO Leadership Award for Capabilities

Altasciences’ Commitment to Supporting Pharma and Biotech With Comprehensive Bioanalytical Services

Altasciences Announces Chris Perkin Appointed Executive Chairman; Marie-Hélène Raigneau Appointed Chief Executive Officer

Angel Reyes Joins Altasciences as General Manager of CDMO Services

Altasciences’ Chief Scientific Officer Named a PharmaVoice 100 Honoree

Altasciences Receives EcoVadis Gold Medal for Environmental, Social, and Governance (ESG) Efforts

Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category